Spanish Red Biotech Pipeline

CIBER

Combined use of biotine and thiamine for prevention and treatment of Hungtington Disease

Type: Biodrugs/ Drugs
Therapeutic area:
Indication: CSIC and the CIBERNED have determined that the combined administration of biotin and thiamine is capable of improving motor symptoms and reducing striatal atrophy associated with Huntington Disease (HD).
Phase: 1Non Regulatory Preclinical